JP2011523650A - ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法 - Google Patents
ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法 Download PDFInfo
- Publication number
- JP2011523650A JP2011523650A JP2011511584A JP2011511584A JP2011523650A JP 2011523650 A JP2011523650 A JP 2011523650A JP 2011511584 A JP2011511584 A JP 2011511584A JP 2011511584 A JP2011511584 A JP 2011511584A JP 2011523650 A JP2011523650 A JP 2011523650A
- Authority
- JP
- Japan
- Prior art keywords
- sensitive adhesive
- delivery system
- drug delivery
- pressure sensitive
- transdermal drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 title claims abstract description 63
- 229960004958 ketotifen Drugs 0.000 title claims abstract description 61
- 238000013271 transdermal drug delivery Methods 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 31
- 201000010099 disease Diseases 0.000 title abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 21
- 239000011505 plaster Substances 0.000 claims abstract description 50
- 239000012458 free base Substances 0.000 claims abstract description 38
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 36
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 27
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims description 14
- 210000000744 eyelid Anatomy 0.000 claims description 12
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 9
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 9
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 9
- 229920005604 random copolymer Polymers 0.000 claims description 9
- 229940057995 liquid paraffin Drugs 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 7
- YRDNVESFWXDNSI-UHFFFAOYSA-N n-(2,4,4-trimethylpentan-2-yl)prop-2-enamide Chemical compound CC(C)(C)CC(C)(C)NC(=O)C=C YRDNVESFWXDNSI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 4
- 239000004902 Softening Agent Substances 0.000 claims 4
- XKWFZGCWEYYGSK-UHFFFAOYSA-N 3,3,5,5-tetramethyl-2-methylidenehexanamide Chemical compound CC(C)(C)CC(C)(C)C(=C)C(N)=O XKWFZGCWEYYGSK-UHFFFAOYSA-N 0.000 claims 3
- 238000012377 drug delivery Methods 0.000 claims 1
- 239000010410 layer Substances 0.000 description 52
- 210000003491 skin Anatomy 0.000 description 36
- 238000009472 formulation Methods 0.000 description 22
- 239000013543 active substance Substances 0.000 description 21
- 239000000853 adhesive Substances 0.000 description 19
- 230000001070 adhesive effect Effects 0.000 description 17
- -1 1-methyl-4-piperidinylidene Chemical group 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 11
- 239000000123 paper Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000037317 transdermal delivery Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 210000000795 conjunctiva Anatomy 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000002759 woven fabric Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920001225 polyester resin Polymers 0.000 description 3
- 239000004645 polyester resin Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011086 glassine Substances 0.000 description 2
- 229960003630 ketotifen fumarate Drugs 0.000 description 2
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 239000011112 polyethylene naphthalate Substances 0.000 description 2
- 229920005672 polyolefin resin Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000005547 chronic conjunctivitis Diseases 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 231100000435 percutaneous penetration Toxicity 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 208000018464 vernal keratoconjunctivitis Diseases 0.000 description 1
- 229940061636 zaditor Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00646—Medication patches, e.g. transcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00659—Plasters adhesive polymeric base
- A61F2013/00663—Plasters adhesive polymeric base acrylic
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5774808P | 2008-05-30 | 2008-05-30 | |
| US61/057,748 | 2008-05-30 | ||
| US12/236,392 US20090297590A1 (en) | 2008-05-30 | 2008-09-23 | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
| US12/236,392 | 2008-09-23 | ||
| PCT/US2008/079211 WO2009145801A1 (en) | 2008-05-30 | 2008-10-08 | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011523650A true JP2011523650A (ja) | 2011-08-18 |
| JP2011523650A5 JP2011523650A5 (enExample) | 2011-11-24 |
Family
ID=41377403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011511584A Pending JP2011523650A (ja) | 2008-05-30 | 2008-10-08 | ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090297590A1 (enExample) |
| EP (1) | EP2296748B1 (enExample) |
| JP (1) | JP2011523650A (enExample) |
| KR (1) | KR20110019382A (enExample) |
| CN (1) | CN102083494B (enExample) |
| AR (1) | AR070031A1 (enExample) |
| ES (1) | ES2458627T3 (enExample) |
| TW (1) | TW200948401A (enExample) |
| WO (1) | WO2009145801A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022163213A (ja) * | 2015-02-02 | 2022-10-25 | 参天製薬株式会社 | ポリアフロンおよびその眼瞼投与 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5241714B2 (ja) | 2006-07-07 | 2013-07-17 | プロテウス デジタル ヘルス， インコーポレイテッド | スマートな非経口送達システム |
| JP5243548B2 (ja) | 2007-10-25 | 2013-07-24 | プロテウス デジタル ヘルス， インコーポレイテッド | 情報システムのための流体伝達ポート |
| WO2009067463A1 (en) | 2007-11-19 | 2009-05-28 | Proteus Biomedical, Inc. | Body-associated fluid transport structure evaluation devices |
| KR101798128B1 (ko) | 2010-02-01 | 2017-11-16 | 프로테우스 디지털 헬스, 인코포레이티드 | 데이터 수집 시스템 |
| SG182824A1 (en) | 2010-02-01 | 2012-09-27 | Proteus Biomedical Inc | Two-wrist data gathering system |
| US20130060209A1 (en) * | 2011-05-12 | 2013-03-07 | Parker Campbell Tyler | Athletic Tape |
| US8900626B2 (en) | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
| WO2014028396A2 (en) * | 2012-08-13 | 2014-02-20 | Hicken Matthew | Therapeutic elastic tape |
| MX2015008021A (es) | 2012-12-21 | 2016-03-04 | Teikoku Pharma Usa Inc | Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos. |
| USD890936S1 (en) | 2018-05-25 | 2020-07-21 | Blacktop Plus, Llc | Therapeutic elastic sports tape |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0491022A (ja) * | 1990-08-07 | 1992-03-24 | Toyama Chem Co Ltd | ケトチフェンのプラスター剤 |
| WO2006036899A2 (en) * | 2004-09-27 | 2006-04-06 | Corium International, Inc. | Transdermal systems for the delivery of estrogens and progestins |
| JP2006169238A (ja) * | 2004-11-22 | 2006-06-29 | Hisamitsu Pharmaceut Co Inc | 薬物含有貼付剤 |
| WO2008038939A1 (en) * | 2006-09-27 | 2008-04-03 | Industry-Academic Cooperation Foundation, Chosun University | Preparation and composition of meloxicam transdermal drug delivery system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2512805B2 (ja) * | 1989-07-14 | 1996-07-03 | 積水化学工業株式会社 | ケトチフェン経皮吸収製剤 |
| JP4205778B2 (ja) * | 1998-04-17 | 2009-01-07 | 久光製薬株式会社 | 貼付製剤 |
| US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
| KR100433614B1 (ko) * | 2000-06-16 | 2004-05-31 | 주식회사 태평양 | 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제 |
| JP4213432B2 (ja) * | 2002-08-28 | 2009-01-21 | 久光製薬株式会社 | 貼付剤 |
| KR20120035220A (ko) * | 2003-01-22 | 2012-04-13 | 센주 세이야꾸 가부시키가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 |
| JPWO2005115355A1 (ja) * | 2004-05-28 | 2008-03-27 | 久光製薬株式会社 | 貼付製剤 |
| JP4924837B2 (ja) * | 2005-04-20 | 2012-04-25 | 千寿製薬株式会社 | 経皮吸収製剤 |
| US20060257460A1 (en) * | 2005-05-13 | 2006-11-16 | Jansen Rolf R | Multilayer drug delivery system with barrier against antagonist exposure |
-
2008
- 2008-09-23 US US12/236,392 patent/US20090297590A1/en not_active Abandoned
- 2008-10-08 EP EP08824894.3A patent/EP2296748B1/en not_active Not-in-force
- 2008-10-08 ES ES08824894.3T patent/ES2458627T3/es active Active
- 2008-10-08 KR KR1020107029270A patent/KR20110019382A/ko not_active Ceased
- 2008-10-08 WO PCT/US2008/079211 patent/WO2009145801A1/en not_active Ceased
- 2008-10-08 CN CN2008801296458A patent/CN102083494B/zh not_active Expired - Fee Related
- 2008-10-08 JP JP2011511584A patent/JP2011523650A/ja active Pending
- 2008-10-29 AR ARP080104724A patent/AR070031A1/es unknown
- 2008-10-30 TW TW097141712A patent/TW200948401A/zh unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0491022A (ja) * | 1990-08-07 | 1992-03-24 | Toyama Chem Co Ltd | ケトチフェンのプラスター剤 |
| WO2006036899A2 (en) * | 2004-09-27 | 2006-04-06 | Corium International, Inc. | Transdermal systems for the delivery of estrogens and progestins |
| JP2006169238A (ja) * | 2004-11-22 | 2006-06-29 | Hisamitsu Pharmaceut Co Inc | 薬物含有貼付剤 |
| WO2008038939A1 (en) * | 2006-09-27 | 2008-04-03 | Industry-Academic Cooperation Foundation, Chosun University | Preparation and composition of meloxicam transdermal drug delivery system |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022163213A (ja) * | 2015-02-02 | 2022-10-25 | 参天製薬株式会社 | ポリアフロンおよびその眼瞼投与 |
| JP7460707B2 (ja) | 2015-02-02 | 2024-04-02 | 参天製薬株式会社 | ポリアフロンおよびその眼瞼投与 |
| JP2024071469A (ja) * | 2015-02-02 | 2024-05-24 | 参天製薬株式会社 | ポリアフロンおよびその眼瞼投与 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102083494B (zh) | 2013-11-13 |
| EP2296748A1 (en) | 2011-03-23 |
| KR20110019382A (ko) | 2011-02-25 |
| EP2296748B1 (en) | 2014-04-02 |
| EP2296748A4 (en) | 2011-09-28 |
| US20090297590A1 (en) | 2009-12-03 |
| ES2458627T3 (es) | 2014-05-06 |
| WO2009145801A1 (en) | 2009-12-03 |
| CN102083494A (zh) | 2011-06-01 |
| AR070031A1 (es) | 2010-03-10 |
| TW200948401A (en) | 2009-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011523650A (ja) | ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法 | |
| Arunachalam et al. | Transdermal drug delivery system: a review | |
| ES2253331T3 (es) | Estructuras y metodos para administrar cannabis a pacientes. | |
| JP4629578B2 (ja) | 眼疾患治療用経皮吸収型製剤 | |
| CN103476404B (zh) | 包含活性剂层和活性剂转化层的透皮组合物 | |
| US20090291127A1 (en) | Transdermal anti-dementia active agent formulations and methods for using the same | |
| RU2764764C2 (ru) | Трансдермальные системы доставки мемантина | |
| US20100080842A1 (en) | Transdermal extended-delivery donepezil compositions and methods for using the same | |
| US20040028726A1 (en) | Transdermal systems for the delivery of clonidine | |
| JPS6214526B2 (enExample) | ||
| Hanumanaik et al. | Design, evaluation and recent trends in transdermal drug delivery system: a review | |
| US20100178307A1 (en) | Transdermal anti-dementia active agent formulations and methods for using the same | |
| JP4001927B2 (ja) | 物理的特性の改善されたポリアクリレートマトリックスを有する経皮吸収または局所プラスターシステム | |
| TW202317112A (zh) | 經電暈放電處理的經皮傳遞系統 | |
| JP7183041B2 (ja) | 経皮薬物送達システムおよびその使用方法 | |
| CN104797245A (zh) | 丙炔基氨基茚满透皮组合物 | |
| JPS62153214A (ja) | 医薬製剤 | |
| TW202317113A (zh) | 使用經皮傳遞系統的組合療法處理 | |
| JPH07277961A (ja) | 経皮吸収製剤 | |
| HK1187817B (en) | Transdermal compositions comprising an active agent layer and an active agent conversion layer | |
| HK1187817A (en) | Transdermal compositions comprising an active agent layer and an active agent conversion layer | |
| Irfani | Design and Evaluation of Transdermal Drug Delivery System of Valsartan | |
| HK1161101A (en) | Transdermal extended-delivery donepezil compositions and methods for using the same | |
| HK1207558B (zh) | 丙炔基氨基茚满透皮组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101208 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110527 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111004 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111004 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130827 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130828 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140422 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140717 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140725 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141021 |